Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
November 05, 2020 at 10:31 AM EST
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration officials said there was enough evidence in clinical trials to prove the therapy’s effectiveness.
